Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formoterol vs Tiotropium in GOLD A/B COPD
NCT03258749Unknown
- Sponsor
- Huashan Hospital
- Start
- Nov 2017
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tiotropium in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Huashan Hospital. Primary endpoint: Postbronchodilator FEV1 at 12 months. Status: unknown.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03258749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03258749.